Cargando…
A Systematic Review of Glucose Transport Alterations in Alzheimer's Disease
Introduction: Alzheimer's disease (AD) is characterized by cerebral glucose hypometabolism. Hypometabolism may be partly due to reduced glucose transport at the blood-brain barrier (BBB) and across astrocytic and neuronal cell membranes. Glucose transporters (GLUTs) are integral membrane protei...
Autores principales: | Kyrtata, Natalia, Emsley, Hedley C. A., Sparasci, Oli, Parkes, Laura M., Dickie, Ben R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8173065/ https://www.ncbi.nlm.nih.gov/pubmed/34093108 http://dx.doi.org/10.3389/fnins.2021.626636 |
Ejemplares similares
-
Glucose transporters in Alzheimer's disease
por: Kyrtata, Natalia, et al.
Publicado: (2021) -
High dose antipsychotic therapy (HDAT) prescibing practice within the south trafford community mental health team
por: Sparasci, Oli, et al.
Publicado: (2021) -
Protein Misfolding, Signaling Abnormalities and Altered Fast Axonal Transport: Implications for Alzheimer and Prion Diseases
por: Zamponi, Emiliano, et al.
Publicado: (2019) -
Epigenetic Alterations in Alzheimer’s Disease
por: Sanchez-Mut, Jose V., et al.
Publicado: (2015) -
The Utility of FDG-PET/CT in Clinically Suspected Paraneoplastic Neurological Syndrome: A Literature Review and Retrospective Case Series
por: Maskery, Mark P., et al.
Publicado: (2017)